AKT1 and neoplasm: These findings are notable and may partially explain the anti-tumor activity seen here as components of the Pi3k/Akt/mTOR pathway are among the most commonly mutated targets in human cancers72, and serve to promote the metabolism, proliferation, motility, and survival of malignant cells73.